Identifier |
Protein names |
Gene names |
Cross reference refseq |
Length |
Species |
A0A024R327
|
Family with sequence similarity 107, member A, isoform CRA_c;
|
FAM107A;
|
NULL
|
175
|
human
|
A0A059QN76
|
NADH-ubiquinone oxidoreductase chain 3; EC 1.6.5.3;
|
ND3;
|
NULL
|
115
|
human
|
A0A059RXH5
|
Cytochrome c oxidase subunit 1; EC 1.9.3.1;
|
COX1;
|
NULL
|
513
|
human
|
A0A087WZT9
|
Serine/threonine-protein kinase H1;
|
PSKH1;
|
NULL
|
353
|
human
|
A0A060VCP5
|
MHC class I antigen; Fragment;
|
HLA-A;
|
NULL
|
181
|
human
|
A0A024R0H3
|
Membrane associated guanylate kinase, WW and PDZ domain containing 3, isoform CRA_a;
|
MAGI3;
|
NULL
|
1150
|
human
|
A0A059QQR4
|
Cytochrome c oxidase subunit 3;
|
COX3;
|
NULL
|
261
|
human
|
A0A059QEM6
|
Cytochrome c oxidase subunit 1; EC 1.9.3.1;
|
COX1;
|
NULL
|
513
|
human
|
A0A059RNS3
|
NADH-ubiquinone oxidoreductase chain 3; EC 1.6.5.3;
|
ND3;
|
NULL
|
115
|
human
|
A0A068BEV6
|
Truncated breast and ovarian cancer susceptibility protein 1; Fragment;
|
BRCA1;
|
NULL
|
126
|
human
|
A0A059RGF9
|
NADH-ubiquinone oxidoreductase chain 4; EC 1.6.5.3;
|
ND4L;
|
NULL
|
98
|
human
|
A0A059QGM3
|
Cytochrome c oxidase subunit 3;
|
COX3;
|
NULL
|
261
|
human
|
A0A024RDY0
|
RAN binding protein 5, isoform CRA_d;
|
RANBP5;
|
NULL
|
1097
|
human
|
A0A024R4N0
|
HCG1640809, isoform CRA_b;
|
NULL
|
NULL
|
322
|
human
|
A0A068BQ23
|
Cytochrome b;
|
CYTB;
|
NULL
|
380
|
human
|
A0A087X2E2
|
Carcinoembryonic antigen-related cell adhesion molecule 8;
|
CEACAM8;
|
NULL
|
344
|
human
|
F8W8B0
|
MOB-like protein phocein;
|
MOB4;
|
NULL
|
51
|
human
|
A0A059RQV0
|
Cytochrome c oxidase subunit 1; EC 1.9.3.1;
|
COX1;
|
NULL
|
513
|
human
|
A0A059RYZ4
|
Cytochrome c oxidase subunit 3;
|
COX3;
|
NULL
|
261
|
human
|
O19737
|
MHC HLA-DR-beta cell surface glycoprotein; Fragment;
|
HLA-DRB;
|
NULL
|
29
|
human
|